IL-33 has been previously involved in cognitive defects observed in neuropathological conditions such as reflected in Alzheimer’s disease, multiple sclerosis, and experimental cerebral malaria [1, 10, 22]. Here, IL33 is linked to early-onset autosomal dominant Alzheimer disease.